Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Guangzhou Xiling Biotechnology Co., Ltd.

Clinical trials sponsored by Guangzhou Xiling Biotechnology Co., Ltd., explained in plain language.

Trials to join now! 1

Experimental cell therapy takes on Hard-to-Treat cancers

Disease control Recruiting now

This early-stage trial is testing a new treatment called CEL001, made from natural killer (NK) immune cells, in 13 people with advanced solid tumors that have not responded to standard therapies. The main goal is to see if the injection is safe and tolerable, while also checking …

Phase 1 • Sponsor: Guangzhou Xiling Biotechnology Co., Ltd. • Aim: Disease control

Last updated Jun 27, 2026 08:01 UTC